Active Ingredient(s): Nimodipine
FDA Approved: * May 10, 2013
Pharm Company: * ARBOR PHARMS INC
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nymalize Overview

Nimodipine, sold under the brand name Nimotop among others, is a calcium channel blocker originally developed for the treatment of high blood pressure. It is not frequently used for this indication, but has shown good results in preventing a major complication of subarachnoid hemorrhage (a form of cerebral hemorrhage) termed vasospasm; this is now the main use of nimodipine. It was patented in 1971[2] and approved for medical use in the US in 1988.[3] It was ap...

Read more Nymalize Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Nimodipine

Recent Nymalize Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 30mg
  • Solution: 3mg/ml, 60mg/20ml, 6mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nymalize: (4 results)

Sorted by National Drug Code
  • 24338-200 Nymalize 60 mg/20ml Oral Solution by Arbor Pharmaceuticals
  • 24338-205 Nymalize 30 mg/10ml Oral Solution by Arbor Pharmaceuticals
  • 24338-230 Nymalize 30 mg/5ml Oral Solution by Arbor Pharmaceuticals
  • 24338-260 Nymalize 60 mg/10ml Oral Solution by Arbor Pharmaceuticals

Other drugs which contain Nimodipine or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 August 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA